Valensa to launch line with BiovaFlex
Valensa International of Florida has entered into a license agreement with Biova of Iowa that will allow Valensa to include the patented BiovaFlex water-soluble eggshell membrane ingredient in a proprietary new series of formulated joint-health products. In addition, Valensa was granted a worldwide exclusive license for BiovaFlex in gummy-type chewables for joint health. In late 2009, Valensa announced that it had filed provisional patents for a range of joint, cardiovascular and eye-health care dietary supplements and medical food formulations featuring Aker BioMarine krill oil and other scientifically sound condition-specific ingredients. The agreement with Biova is a continuation of Valensa's programme in the area of joint health.

Study supports benefits of Alguard
Results of a new clinical study show that Alguard, an all-natural cosmetics ingredient developed by Frutarom, provides immediate beauty enhancement when applied to skin. Alguard is known for its ability to provide long-term protection to skin, but this study is the first to demonstrate it can also offer skin enhancement immediately after the first usage. Following the encouraging results, Frutarom has released a preservative-free, eco-certified version of Alguard. Alguard is derived from a polysaccharide surrounding red microalgae adapted to the extreme conditions of the ocean tidal zone. This polysaccharide is the survival secret of the red microalgae. It forms a protective layer, shielding the algae from harsh elements. Alguard forms a similar protective layer, or 'active shield,' when applied to the skin.

Twin Rivers Tech changes name
SourceOne Global Partners has announced that its omega-3 partner, Twin Rivers Technologies (TRT), has transferred its ownership to Felda IFFCO Sdn Bhd (FISB), a joint venture between the Felda Group of Malaysia and IFFCO Group of United Arab Emirates. TRT's name will change to FINA (FELDA IFFCO North America), effective immediately, and it will continue to operate out of its state-of-the-art facility in Cincinnati, Ohio. Source One remains FINA's exclusive marketing partner, responsible for building and managing a strategic marketing and distribution infrastructure that delivers market access for FINA's US-produced OmegaChoice brand of concentrated omega-3s.

Danisco expands Wisconsin plant
Danisco is in the midst of a major plant expansion of its cultures plant in Madison, Wisconsin. The investment includes one of the largest ultra-cold storage facilities in the US, as well as pelletizing production rooms. The new Madison facilities are expected to go into operation in August 2010 to meet the growing US demand for frozen Direct Vat Inoculants (DVI) cultures at the highest quality standard. The expansion is part of the $90 million that will be invested by Danisco to increase its cultures capacity worldwide. The footprint of the Madison manufacturing site will increase by nearly a third with a new shipping area, offices, a maintenance shop, as well as the new storage and pelletizing area.

DVA International opens US branch
DVA International has expanded its operations with the opening of a US subsidiary, DVA AMERICA Corp, to distribute its strategic product categories, consisting of vitamin C, sweeteners, nutraceuticals and other vitamins, across North America. The new team is composed of health and nutrition-ingredient experts in sales, marketing, quality and distribution management.

DSM expanding R&D facilities
DSM is growing its existing research and development facilities in Parsippany, New Jersey. The new Nutrition Innovation Center will bring together DSM's extensive laboratory capabilities for the beverage, bakery, dairy, savoury, dietary-supplements and personal-care market sectors. It will combine expertise from two key business groups — DSM Nutritional Products and DSM Food Specialties. The centre will further facilitate DSM's interdisciplinary approach to advancing differentiation through applications, as well as optimizing support services for its global customers.

Lutemax ingredient verified by ConsumerLab
OmniActive Health Technologies' Lutemax (free lutein) 20 per cent oil suspension ingredient was tested in an independent laboratory blinded to the ingredient's identity and recognized as an 'Approved Quality Product' by through its Raw Materials Testing Program. confirmed that the ingredient contained 100 per cent of its claimed amount of lutein and zeaxanthin, and did not exceed the state of California's Prop 65 limits for lead.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.